TARS - Tarsus Pharmaceuticals Inc. (TARS) Q1 2024 Earnings Call Transcript
2024-05-08 21:45:35 ET
Tarsus Pharmaceuticals, Inc. (TARS)
Q1 2024 Earnings Conference Call
May 8, 2024 04:30 PM ET
Company Participants
David Nakasone - Head of Investor Relations
Bobby Azamian - Chief Executive Officer and Chairman
Aziz Mottiwala - Chief Commercial Officer
Jeff Farrow - Chief Financial Officer and Chief Strategy Officer
Sesha Neervannan - Chief Operating Officer
Conference Call Participants
Eddie Hickman - Guggenheim Securities
Balaji - Barclays
Francois Brisebois - Oppenheimer
Jason Gerberry - Bank of America
Andrea Tan - Goldman Sachs
Corey Jubinville - Life Sci Capital
Presentation
Operator
Good afternoon, and welcome to Tarsus's First Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded.
At this time, I would like to turn the call over to David Nakasone, Head of Investor Relations, to lead off the call. Please go ahead.
David Nakasone
Thank you. Before we begin, I encourage everyone to go to the Investors Section of the Tarsus website to view the earnings release and related materials we will be discussing today.
Joining me on the call this afternoon are Bobby Azamian, our Chief Executive Officer and Chairman; Aziz Mottiwala, our Chief Commercial Officer; Jeff Farrow, our Chief Financial Officer and Chief Strategy Officer; and joining us for the question-and-answer session Sesha Neervannan, our Chief Operating Officer.
I'd like to draw your attention to Slide 3, which contains our forward-looking statements. During this call, we will be making forward-looking statements that are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors contained in our SEC filings for additional detail....
Tarsus Pharmaceuticals, Inc. (TARS) Q1 2024 Earnings Call Transcript